- Investing Ideas
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
4
0 new
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €346.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.74
7D
-3.9%
1Y
-25.1%
Heidelberg Pharma
Market Cap: €121.6m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, Europe, China, the United States, and internationally.
HPHA
€2.58
7D
0%
1Y
-34.8%
Darwin
Market Cap: €95.4m
Operates in the healthcare industry.
7V0
€7.95
7D
32.5%
1Y
n/a
Cantourage Group
Market Cap: €77.8m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.16
7D
-1.0%
1Y
6.2%